Huilin Hu
- Virology top 5%
- Microbiology top 5%
- Epidemiology top 10%
- Oncology top 10%
-
- Advanced Breast Cancer Therapies 9
-
- Circular RNAs in diseases 9
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 5
- Breast Cancer Treatment Studies 4
-
- Diet and metabolism studies 4
-
- Heart Failure Treatment and Management 4
- Cardiovascular Function and Risk Factors 3
- Co-authors
- Lawrence CoreyJudith E. ZehTimothy W. SchackerChanglin ZhaiEdgar L. HillGang QianGuping TangPeter Mesenbrink
- Journals
- Frontiers in Cardiovascular Medicine (7 papers)Clinical Cardiology (4 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Huilin Hu
52 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 104
- Orthopedics and Sports Medicine 233
- Virology 110
- Microbiology 81
- Epidemiology 337
- Oncology 245
Countries citing papers authored by Huilin Hu
This map shows the geographic impact of Huilin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huilin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huilin Hu more than expected).
Fields of papers citing papers by Huilin Hu
This network shows the impact of papers produced by Huilin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huilin Hu. The network helps show where Huilin Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huilin Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 18 | |
| 11 | 2021 | 5 | |
| 12 | 2020 | 14 | |
| 13 | 2020 | 25 | |
| 14 | 2019 | 1 | |
| 15 | 2017 | 19 | |
| 16 | 2016 | 5 | |
| 17 | Polymorphism of klotho G-395A and susceptibility of coronary artery disease in East-Asia population: a meta-analysis. | 2015 | 5 |
| 18 | 2014 | 2 | |
| 19 | 2009 | 100 | |
| 20 | 2007 | 170 |
About Huilin Hu
Huilin Hu is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine, Applied Microbiology and Biotechnology, Pulmonary and Respiratory Medicine and Virology, having authored 54 papers that have together received 1.2k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (9 papers), Circular RNAs in diseases (9 papers), Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers), Diet and metabolism studies (4 papers), Heart Failure Treatment and Management (4 papers), Breast Cancer Treatment Studies (4 papers) and Cardiovascular Function and Risk Factors (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (233 citations), Virology (110 citations), Microbiology (81 citations), Epidemiology (337 citations) and Oncology (245 citations). Huilin Hu has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Lawrence Corey, Judith E. Zeh, Timothy W. Schacker, Changlin Zhai, Edgar L. Hill, Gang Qian, Guping Tang, Peter Mesenbrink, Steven Boonen and Erik Fink Eriksen. Their work appears in journals such as Frontiers in Cardiovascular Medicine, Clinical Cardiology, Journal of Clinical Oncology, Journal of Bone and Mineral Research and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.